Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs.
about
Transforming growth factor-beta modulates the expression of nitric oxide signaling enzymes in the injured developing lung and in vascular smooth muscle cells.SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension.Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.Therapeutic approaches using nitric oxide in infants and children.Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newbornRole of veins in regulation of pulmonary circulation.Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cellsSoluble guanylate cyclase modulates alveolarization in the newborn lung.Regulation of soluble guanylyl cyclase-alpha1 expression in chronic hypoxia-induced pulmonary hypertension: role of NFATc3 and HuR.Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.Regulation of the pulmonary circulation in the fetus and newborn.Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension.Vasodilator compounds derived from plants and their mechanisms of action.Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension.Endothelial cell regulation of pulmonary vascular tone, inflammation, and coagulation.Cyclic stretch induces inducible nitric oxide synthase and soluble guanylate cyclase in pulmonary artery smooth muscle cellsHeme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide.Characterization of the human alpha1 beta1 soluble guanylyl cyclase promoter: key role for NF-kappaB(p50) and CCAAT-binding factors in regulating expression of the nitric oxide receptor.Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension.Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension.Endothelial alterations during inhaled NO in lambs with pulmonary hypertension: implications for rebound hypertension.Effects of BAY 41-2272, a soluble guanylate cyclase activator, on pulmonary vascular reactivity in the ovine fetus.Maturational changes in the regulation of pulmonary vascular tone by nitric oxide in neonatal rats.Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress.Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep.Effect of long-term high-altitude hypoxia on fetal pulmonary vascular contractility.
P2860
Q33728207-57CB16BE-7816-41B9-B6AB-478ECBC7EDB9Q33994653-6DF21C37-7A96-45AC-9C1D-7A5981985813Q35047294-BF4FB4D3-48EA-4B26-8CFD-5F4CC1DC59F2Q35165230-9082D6AB-D39D-4A42-9CFC-E49B188E504AQ35543584-FA9C7D76-056D-452D-87C0-72617615C8CCQ35850324-09D33870-B2D7-4617-B837-9DA8AC926132Q36004121-F1DF1D0C-EBF7-4C91-85F6-D95FECC3D969Q36498599-1E8150E4-0E62-448C-8C6A-CC024D9943E6Q37234894-1B5B924D-D9DF-4557-9BF0-C75B3BA2D0FCQ37337510-5D3099EE-BC7A-419B-8C79-AF38A4FA7422Q37420916-1606A631-A65A-4BD1-94F8-67B2386AAC6AQ37510031-B94E1F29-4CCC-4B05-BF34-466D8BDBE41EQ37801516-AF6F7DDD-3399-470D-BD90-E268CE2487EEQ37893072-D64C34D7-530F-4C6C-B5C8-01F93C5DF03EQ38107797-5D995921-B2EB-472E-B9C2-742E2428EAE1Q38119018-7BA985DD-4682-4EDE-B4CC-BB483B1B7ABCQ38423843-276ABC92-C639-4282-89EF-A9FA5201F484Q39463724-7B8B4C2E-98EA-48A5-BAB3-C44EB110CC2AQ39624782-7CD9FD6D-E3E6-4E2D-ADA6-2B9ECBE3EF94Q40088433-302DABC1-E898-40FD-A124-3962E3F6CF06Q43226235-57C8A461-F615-4342-A2B9-8B4A889C9910Q43732342-E14DE745-B968-4BBD-9A99-5E8341DE65D2Q45044072-0C7CD894-F8C7-4C01-97BE-8827708EACF5Q45193709-5A78B0E8-D4FC-44FE-AF4B-24C13F285B4DQ45870860-92C3033A-BD29-48D2-8DE1-DDD73D4A1E78Q46403664-B2690190-5D20-4210-88A2-8E8980243A00Q46554951-2D20CED8-12CF-4B7C-8DF0-15E474FC1F87Q46664719-429027BD-E8BA-40FF-9CFC-8D81CEA63EFA
P2860
Pulmonary hypertension alters soluble guanylate cyclase activity and expression in pulmonary arteries isolated from fetal lambs.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pulmonary hypertension alters ...... ies isolated from fetal lambs.
@ast
Pulmonary hypertension alters ...... ies isolated from fetal lambs.
@en
type
label
Pulmonary hypertension alters ...... ies isolated from fetal lambs.
@ast
Pulmonary hypertension alters ...... ies isolated from fetal lambs.
@en
prefLabel
Pulmonary hypertension alters ...... ies isolated from fetal lambs.
@ast
Pulmonary hypertension alters ...... ies isolated from fetal lambs.
@en
P2093
P2860
P1476
Pulmonary hypertension alters ...... ies isolated from fetal lambs.
@en
P2093
Nickerson PA
Russell JA
Steinhorn RH
P2860
P304
P356
10.1002/1099-0496(200102)31:2<97::AID-PPUL1016>3.0.CO;2-K
P577
2001-02-01T00:00:00Z